Skip to main content
← Back to work

Works cited by this work

177 works

Work: NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy

  1. Hallmarks of Cancer: The Next Generation

    Douglas Hanahan, Robert A. Weinberg

    Review article201118 citations
    ABI
  2. NLRP3 inflammasome in cancer and metabolic diseases

    Bhesh Raj Sharma, Thirumala‐Devi Kanneganti

    Review article20214 citations
    ABI
  3. RETRACTED: Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms

    Hasan Slika, Hadi Mansour, Nadine Wehbe +7

    Review article20223 citations
    ABI
  4. Kaempferol: A potential agent in the prevention of colorectal cancer

    Hamid Reza Nejabati, Leila Roshangar

    Review article20223 citations
    ABI
  5. Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation

    Shankar S. Iyer, Qiong He, John R. Janczy +11

    Article20132 citations
    ABI
  6. Clinical Pharmacokinetics of Doxorubicin

    P A Speth, Q.G.C.M. van Hoesel, C. Haanen

    Review article19882 citations
    ABI
  7. Doxorubicin: The Good, the Bad and the Ugly Effect

    Cristina Carvalho, Renato X. Santos, Susana Cardoso +4

    Review article20092 citations
    ABI
  8. Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

    Yong Lin, Ranxin Shi, Xia Wang +1

    Review article20082 citations
    ABI
  9. Structural and Chemical Biology of Terpenoid Cyclases

    David W. Christianson

    Review article20172 citations
    ABI